Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC is a research paper published in The Journal of Experimental Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 56 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CA175112
National Institutes of Health
Grant: CA118113
National Institutes of Health
Grant: CA178730
National Institutes of Health
Grant: CA217482
NCI NIH HHS
Grant: R01 CA175112
NCI NIH HHS
Grant: R41 CA217482
NCI NIH HHS
Grant: R42 CA217482
NCI NIH HHS
Grant: R01 CA118113
NCI NIH HHS
Grant: U44 CA217482
National Institutes of Health
Grant: 5U44CA217482-05
Development of a protein drug for pancreatic cancer treatment
National Institutes of Health
Grant: 5R01CA175112-05
Development of anti-angiogenesis therapy targeting integrin
National Institutes of Health
Grant: 2R01CA118113-06A1
P68 and Ca-calmodulin interaction in cell migration
Georgia Cancer Coalition
Georgia State University
FWCI
3.39
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals